Results 181 to 190 of about 140,614 (262)

Mainland diversification and recent island lineages in the reduviid genus Tapirocoris: an integrative taxonomic framework with four new species

open access: yesInsect Science, EarlyView.
Using an integrative taxonomic framework that combines COI DNA barcodes, geometric morphometrics and phylogeography, we revise the assassin bug genus Tapirocoris and recover seven well‐supported species, including four newly described cryptic species.
Ping Zhao   +8 more
wiley   +1 more source

Sensory Biology of the Franciscana (Pontoporia blainvillei, Pontoporiidae, Cetartiodactyla): Ontogenetic Modifications of Vibrissae and Vibrissal Crypts

open access: yesIntegrative Zoology, EarlyView.
The transition of cetaceans from a terrestrial to an aquatic environment involved a crucial sensory adaptation to environments with limited visibility. Vibrissae, important mechanoreceptors, undergo an ontogenetic transformation in odontocetes. This research describes the histomorphology of vibrissae and crypts at different developmental stages ...
Cecilia Mariana Krmpotic   +10 more
wiley   +1 more source

Frontal Lobe Epilepsy Presenting With Unilateral Eye Closure

open access: yes
Neurology and Clinical Neuroscience, EarlyView.
Yuki Mizumoto   +6 more
wiley   +1 more source

Australian Practical Guide on the Management of Muscle‐Invasive Bladder Cancer

open access: yesAsia-Pacific Journal of Clinical Oncology, EarlyView.
Australia's management of muscle‐invasive bladder cancer is evolving, with increased use of perioperative therapy and emerging immunotherapies. However, challenges such as cisplatin ineligibility, limited access, and costs persist. Expanding bladder‐sparing approaches, precision medicine, and integrated care pathways will be key to improving outcomes ...
Dickon Hayne   +6 more
wiley   +1 more source

SAKK 35/14 randomized trial of rituximab with or without ibrutinib for patients with untreated follicular lymphoma

open access: yesBritish Journal of Haematology, EarlyView.
Summary The randomized phase II SAKK 35/14 trial, conducted by the Swiss Group for Clinical Cancer Research (SAKK) and the Nordic Lymphoma Group (NLG), compared efficacy and safety of rituximab (375 mg/m2 intravenously for 4 weeks followed by maintenance every 2 months for 24 months) plus placebo (arm A) versus the same schedule of rituximab plus ...
Maria Cristina Pirosa   +25 more
wiley   +1 more source

Unusual [<sup>18</sup>F]FDOPA PET-CT maging of insulinomas in children. [PDF]

open access: yesEJNMMI Rep
Auckburally SH   +6 more
europepmc   +1 more source

[18F]fluorodeoxyglucose PET/CT refines staging and treatment selection in high‐risk upper tract urothelial carcinoma

open access: yesBJU International, EarlyView.
Objectives To evaluate the incremental clinical value of [18F]fluorodeoxyglucose positron emission tomography/computed tomography ([18F]FDG‐PET/CT) beyond contrast‐enhanced computed tomography (CECT) for primary staging of suspected high‐risk upper tract urothelial carcinoma (UTUC).
Renee A. G. Lijnen   +8 more
wiley   +1 more source

Application of [<sup>18</sup>F]NaF and [<sup>18</sup>F]FDG PET/CT to Assess Molecular Calcification and Glucose Metabolism in Thyroid Cartilage. [PDF]

open access: yesCartilage
Motamedi N   +10 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy